In the present study, the induction of oxidative stress was examined in the testis of alloxaninduced diabetic rabbits. In addition, the protective effect of repaglinide, an oral anti-diabetic, at a dose of 1 mg daily was studied after four and eight weeks of the treatment. For these purposes, the levels of superoxide dismutase (Cu,Zn-SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GSSG-R), glutathione (GSH), ascorbic acid (AA), lipid peroxidation products (LPO) and protein carbonyl groups (PCG) were quantified. Hyperglycemia resulted in significant increases in the antioxidative enzymes, Cu, Zn-SOD, CAT, GSH-Px, and GSSG-R after four and eight weeks, respectively. There was also an increase in GSH level, and a decrease in the level of AA. These effects were accompanied by an elevation in testicular LPO levels and PCG levels. Repaglinide was found to normalize the activity of GSSG-R and levels of GSH and AA, and blunted the increased lipid peroxidation, however no decrease in PCG levels were observed. In conclusion, some oxidative changes provoked in the testis of rabbits by hyperglycemia, were found to be reduced with repaglinide treatment at therapeutic dose.
Introduction
The risk of oxidative damage is especially high for steroid producing tissues. Beside oxidative phosphorylation, such tissues use molecular oxygen for steroid biosynthesis itself. The reactions of the cytochrome P450 enzymes, with their substrates such as cholesterol and its metabolites, are further sources of free radicals [1, 2] . In diabetes, a relationship between oxidative stress and testicular dysfunction is particularly emphasized [3] [4] [5] [6] . In the present study, the induction of oxidative stress was examined in the testis of alloxaninduced diabetic rabbits. In addition, the antioxidative effect of repaglinide, an oral anti-diabetic drug, was studied after four and eight weeks of the treatment.
Repaglinide is a hypoglycemic agent with a unique molecular structure and mechanism of action. It is a benzoic acid derivative which acts on the sulphonylurea receptor SUR1 [7, 8] . Some results have demonstrated that repaglinide might result in a positive action on the antioxidative defense [9, 10] . Several studies have also shown that sulphonylureas have similar properties [11] [12] [13] . However, these effects in type 2 diabetes mellitus are difficult to interpret, as any action could not be separated from effects mediated via increased insulin secretion. In the present study, the alloxan-induced diabetic animals were not insulin-resistant but insulin-deficient and repaglinide had no significant action on insulin and glucose concentrations [14] . Therefore, the potential antioxidative effect of the drug should be further investigated and confirmed. In type 2 diabetic patients treated with repaglinide, this effect may contribute to more effective therapy of diabetes and its complications.
Experimental procedures

Animals
The Guidelines of Medical University of Lublin Animal Ethics Committee were followed while using live animals. Diabetes was induced by injection of 80 mg/kg of alloxan. The animals which survived (53%) developed a state of permanent hyperglycemia. The rabbits were divided into four groups of 10 animals: normal control (Group C), normal treated with repaglinide (Group CR), diabetic control (Group D), and diabetic treated with repaglinide (Group DR). Glucose concentration was measured at the start and the end of experiment, and monitored weekly. Two weeks after the alloxan injection, administration of repaglinide at a dose of 1 mg/daily was started and continued for four and eight weeks. At the end of each experimental period, five of the animals from each group were anaesthetized with pentobarbital sodium (60 mg/kg) and immediately opened surgically. The testes were removed and processed by homogenization procedure. The homogenates were centrifuged at 20,000 × g for 20 min at 4
• C to discard the cell debris.
The supernatants were stored at −70 • C until biochemical measurements.
Chemicals used in the present study were purchased from Sigma Chemical Co. (USA) and ICN Biomedicals INC. (USA). Repaglinide was obtained as a gift sample from Novo Nordisk A/S (Denmark). Concentration of glucose was estimated with a glucometer Precision QID from Abbott UK Ltd. (UK). Concentration of insulin in plasma was determined using commercially available Ultrasensitive Insulin ELISA kit from DRG Diagnostics (Germany) and Bio-Tek ELX800 absorbance microplate reader from Bio-Tek Instruments Inc. (USA).
Protein content was determined by the method of Lowry using bovine serum albumin as standard [15] . Superoxide dismutase (Cu,Zn-SOD), glutathione (GSH) and lipid peroxidation products (LPO) were determined using the kits from Oxis International SA (USA). LPO were determined as the sum of malondialdehyde and 4-hydroxyalkenals according to the respective manufacturer's instruction. CAT activity was measured by the method of Aebi [16] . The reduction rate of H 2 O 2 was followed at 240 nm at room temperature. In the assay of GSH-Px, oxidized glutathione (GSSG) was recycled to its reduced state (GSH) by glutathione reductase (GSSG-R) in the presence of NADPH. This process was monitored by measurement of changes in absorbance at 340 nm, due to oxidation of NADPH to NADP [17] . Similarly, the GSSG-R assay was based on the reduction of GSSG and subsequent oxidation of NADPH to NADP [18] . The activity was expressed as mU/mg protein, where 1 mU is the amount of the enzyme required to oxidize 1 nmol of NADPH per min. Ascorbic acid (AA) concentration was assayed using a simple reaction with phosphotungstate reagent and absorbance measured at 700 nm [19] . The extent of protein oxidation was determined by measuring the protein carbonyl content by using the reaction with 2,4-dinitrophenylhydrazine [20] .
Statistical analysis
All values in Table 1 were expressed as the mean ± SE. The significance of differences was determined with Kruskal-Wallis and Mann-Whitney's U tests. Differences with a probability value of less than 0.05 were considered significant.
Results
In chronic hyperglycemia, there was an elevation of testicular Cu,Zn-SOD activity by 65% and 51% as well as CAT activity by 67% and 77% as compared to control animals after four and eight weeks, respectively. There was an increase in GSH-Px activity by 72 and 27%, and GSSG-R activity by 33 and 28%, as well as in GSH level by 22 and 17%. In diabetic testis, AA level was diminished by 36 and 27% as compared to control animals. At this time, there was an increase of LPO level by 56 and 59%, and PCG level by 57 and 61%.
In diabetic testis, repaglinide did not affect Cu,Zn-SOD, CAT and GSH-Px activities but normalized GSSG-R activity, GSH and AA levels. With repaglinide treatment, LPO level was reduced by 15 and 16% as compared to diabetic non-treated group. Throughout the course of treatment, the drug did not affect a testicular level of PCG (Table 1) . 
Table 1
Effect of repaglinide on superoxide dismutase (Cu,Zn-SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GSSG-R), glutathione (GSH), ascorbic acid (AA), lipid peroxidation products (LPO) and protein carbonyl groups (PCG) in testis of control and diabetic rabbits; values are mean ± SE (n = 5)
Discussion
In both insulin dependent and non-insulin dependent diabetes, the occurrence of oxidative stress was confirmed [21] [22] [23] . In mammalian cells, mitochondria are the major source of free radical formation by oxidative phosphorylation. In steroidogenic tissues, mitochondria generate additional ROS as products of steroidogenesis itself. Therefore, diabetic subjects are at significantly increased risk of developing oxidative alterations in some endocrine tissues [24, 25] . In the present study, the enhanced testicular SOD, CAT, GSH-Px and GSSG-R activities may be a response to increased production of reactive oxygen species. The induction of testicular antioxidant enzymes are potential evidence for adaptive changes in the defense mechanism against oxidative stress. However with time, this antioxidant defense is insufficient to remove excessive radicals, resulting in the occurrence of oxidative stress [6] . The enhanced lipid and protein oxidation observed in diabetic tissue in the present experiment supports this.
The increase in GSH level in diabetic testis is rather unexpected because typical changes are reported as significant decreases [4, 26] . However, increased GSH content has previously been reported in diabetic testis [3, 6] and other tissues of diabetic animals [22, 27] . The induction of the GSH system in a diabetic state may also support evidence for adaptive changes in the defense mechanism against oxidative stress. This may be the result of restoration of GSH level by increased synthesis, uptake from the circulation, or its regeneration from protein mixed disulfides [22] .
In a previous study, testicular antioxidants such as SOD, CAT and GSSG-R as well as GSH decreased below normal values in alloxan-treated rats [4] . The authors supposed that a decrease in testicular GSH level could be attributed to the inhibition of GSSG-R activity which was responsible for regeneration of GSH from its oxidized form. In another study, diabetes resulted in an increase in testicular GSH-Px activity but did not affect the level of GSH [5] . A possible explanation for discrepancies between these results and the results obtained in the present study might be differences in the degree and duration of hyperglycemia.
It is well known that ascorbic acid scavenges superoxide anions, hydrogen peroxide, hydroxyl radicals, singlet oxygen and reactive nitrogen species. Normally, it is present in high concentrations in many mammalian tissues, including the steroidogenic ones [24] . After the alloxan injection, a marked fall in the level of ascorbic acid in diabetic testis and an increase in its urinary excretion has been reported [4] . Similar decrease in the level of AA was observed in the present study. The observed increase in lipid peroxidation is in agreement with similar findings concerning testes and other diabetic tissues [4, 10, 11] . This process is considered to be a major mechanism by which ROS can cause tissue damage leading to impaired cellular functions and alterations in the physico-chemical properties of cellular membranes [22] .
Under conditions of severe oxidative stress, the excessive ROS generation leads to protein modifications. Protein molecules may be damaged directly by specific interac-tions of oxidants with particularly susceptible amino acids, or they may also be modified indirectly, with reactive carbonyl compounds formed by the auto-oxidation of carbohydrates and lipids, with eventual formation of advanced glycation end products [28] . In the present study, the increase in the level of protein carbonyl groups, commonly accepted oxidative modification marker, could have been due to production of ROS that exceeded the capacity of the antioxidant defense. These results confirm that even though the antioxidant defense was increased, with time it is insufficient to remove excessive ROS.
It seems reasonable that agents with antioxidant activity may offer additional benefit to diabetic patients and can be useful in preventing or delaying the development of diabetic complications. In the present study, treatment with repaglinide normalized the testicular activity of GSSG-R as well as the levels of GSH and AA. At the same time the LPO level was significantly decreased. This could mean that there was an initial increase in endogenous antioxidant activity due to excessive production of ROS. With time the antioxidant defense was insufficient to remove excessive radicals, resulting in the occurrence of oxidative stress. Administration of repaglinide could reduce oxidative stress with a resulting modulation of enhanced antioxidative defense and diminution in lipid peroxidation. An increase of AA level in diabetic tissue after repaglinide was similar to that observed in the heart and plasma of diabetic rabbits [29, 30] . In turn, a decrease of LPO level in diabetic testis after repaglinide was similar to its effect observed in the serum of type 2 diabetic patients [10] .
It is possible that repaglinide, being a benzoic acid derivative can exert some antioxidative properties by breaking the chain reactions or reducing the oxidation rate [31, 32] . On the other hand, repaglinide acts with a similar mechanism to that of sulphonylureas and mitiglinide. As was stated in the literature, they were reported to possess some antioxidative properties [11] [12] [13] 33] . However, the precise mechanism of their action is not clear from these reports and further studies should be conducted to support the general conclusion.
The PCG level in diabetic testis was not affected with repaglinide treatment. Perhaps, a longer period of treatment may be necessary to normalize the protein oxidative status of animals exposed to chronic hyperglycemic conditions. It is also possible that the antioxidative properties of the drug can be enhanced by more extensive therapy with higher daily doses of the drug.
In conclusion, some oxidative changes in diabetic testis were reduced with repaglinide treatment at therapeutic dose. Confirmation of this protective effect of repaglinide in larger clinical studies will provide an additional indication for its choice in the treatment of diabetes mellitus.
